Novo Nordisk's semaglutide ... about the opportunities oral semaglutide represents as a new oral anti-diabetic agent to further improve type 2 diabetes treatment," he added.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...